LAG-3 / Janelia Fluor 585 / favezelimab

Product Details
Supplier Novus Biologicals, a Bio-Techne brand
Catalog #: NBP3-28542JF585 (View supplier product page)
Size 100 μl
Price $379.00
Antigen LAG-3
Clone favezelimab
Host Human
Isotype IgG4
Conjugate Janelia Fluor 585
Target Species Human
Applications FC, ELISA, Functional
Description LAG-3 Antibody (favezelimab) [Janelia Fluor® 585]
About LAG-3 and Janelia Fluor 585
LAG-3 Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4. [provided by RefSeq, Jul 2008]
Janelia Fluor 585 Janelia Fluor® 585 was developed at the Janelia Campus of the Howard Hughes Medical Institute but is commercialized by other vendors. The Janelia Fluor®s family is unique in that the fluorophores are cell-permeable and are available in photoactivatable forms. These fluorophores were developed for super-resolution microscopy (STED, PALM and STORM) and live-cell microscopy in the HaloTag and SNAP-tag versions. Janelia Fluor® 585 has an excitation peak at 585 nm and an emission peak at 609 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

Janelia Fluor 585 Excitation and Emission Spectra